87 related articles for article (PubMed ID: 23223009)
1. A commentary on Analysis of ZNF350/ZBRK1 promoter variants and breast cancer susceptibility in non-BRCA1/2 French Canadian breast cancer families.
Kiyotani K; Katagiri T
J Hum Genet; 2013 Feb; 58(2):58. PubMed ID: 23223009
[No Abstract] [Full Text] [Related]
2. Analysis of ZNF350/ZBRK1 promoter variants and breast cancer susceptibility in non-BRCA1/2 French Canadian breast cancer families.
Plourde KV; Labrie Y; Desjardins S; Belleau P; Ouellette G; Durocher F;
J Hum Genet; 2013 Feb; 58(2):59-66. PubMed ID: 23151675
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high-risk non BRCA1/2 French Canadian breast and ovarian cancer families.
Desjardins S; Belleau P; Labrie Y; Ouellette G; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Pichette R; Plante M; ; Durocher F
Int J Cancer; 2008 Jan; 122(1):108-16. PubMed ID: 17764113
[TBL] [Abstract][Full Text] [Related]
5. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
Tonin PN
Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women.
Huo X; Lu C; Huang X; Hu Z; Jin G; Ma H; Wang X; Qin J; Wang X; Shen H; Tang J
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1569-75. PubMed ID: 19484476
[TBL] [Abstract][Full Text] [Related]
8. Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
Mol Carcinog; 2010 Jun; 49(6):545-55. PubMed ID: 20306497
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer.
Guénard F; Pedneault CS; Ouellette G; Labrie Y; Simard J; ; Durocher F
Genet Test Mol Biomarkers; 2010 Aug; 14(4):515-26. PubMed ID: 20722467
[TBL] [Abstract][Full Text] [Related]
10. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
Sigurdson AJ; Hauptmann M; Chatterjee N; Alexander BH; Doody MM; Rutter JL; Struewing JP
BMC Cancer; 2004 Mar; 4():9. PubMed ID: 15113441
[TBL] [Abstract][Full Text] [Related]
11. Functional Evaluation of ZNF350 Missense Genetic Variants Associated with Breast Cancer Susceptibility.
Zhang N; Lu Y; Liu X; Yu D; Lv Z; Yang M
DNA Cell Biol; 2018 Jun; 37(6):543-550. PubMed ID: 29653063
[TBL] [Abstract][Full Text] [Related]
12. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
[TBL] [Abstract][Full Text] [Related]
13. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
14. Clinically Significant Unclassified Variants in
Yoon KA; Park B; Lee BI; Yang MJ; Kong SY; Lee ES
Cancer Res Treat; 2017 Jul; 49(3):627-634. PubMed ID: 27658390
[TBL] [Abstract][Full Text] [Related]
15. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
Vos S; Moelans CB; van Diest PJ
Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
[TBL] [Abstract][Full Text] [Related]
16. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
17. Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition.
Rouleau E; Jesson B; Briaux A; Nogues C; Chabaud V; Demange L; Sokolowska J; Coulet F; Barouk-Simonet E; Bignon YJ; Bonnet F; Bourdon V; Bronner M; Caputo S; Castera L; Delnatte C; Delvincourt C; Fournier J; Hardouin A; Muller D; Peyrat JP; Toulas C; Uhrhammer N; Vidal V; Stoppa-Lyonnet D; Bieche I; Lidereau R
Breast Cancer Res Treat; 2012 Jun; 133(3):1179-90. PubMed ID: 22476849
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
[TBL] [Abstract][Full Text] [Related]
19. Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families.
Balleine RL; Provan PJ; Pupo GM; Pathmanathan N; Cummings M; Farshid G; Salisbury EL; Bilous AM; Byth K; ; Mann GJ
Genes Chromosomes Cancer; 2010 Dec; 49(12):1082-94. PubMed ID: 20815029
[TBL] [Abstract][Full Text] [Related]
20. Update on genetic predisposition to breast cancer.
Ahmed M; Lalloo F; Evans DG
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1103-13. PubMed ID: 19671030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
